[go: up one dir, main page]

AU2001243598A1 - Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade - Google Patents

Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade

Info

Publication number
AU2001243598A1
AU2001243598A1 AU2001243598A AU4359801A AU2001243598A1 AU 2001243598 A1 AU2001243598 A1 AU 2001243598A1 AU 2001243598 A AU2001243598 A AU 2001243598A AU 4359801 A AU4359801 A AU 4359801A AU 2001243598 A1 AU2001243598 A1 AU 2001243598A1
Authority
AU
Australia
Prior art keywords
heteroaryl substituted
coagulation cascade
selective inhibition
polycyclic aryl
substituted benzenes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001243598A
Inventor
John J. Parlow
Michael S. South
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia LLC
Original Assignee
Pharmacia LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia LLC filed Critical Pharmacia LLC
Publication of AU2001243598A1 publication Critical patent/AU2001243598A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/46—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
    • C07C323/49—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/63—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001243598A 2000-03-13 2001-03-13 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade Abandoned AU2001243598A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18894300P 2000-03-13 2000-03-13
US60188943 2000-03-13
US25215900P 2000-11-20 2000-11-20
US60252159 2000-11-20
PCT/US2001/007918 WO2001068605A1 (en) 2000-03-13 2001-03-13 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade

Publications (1)

Publication Number Publication Date
AU2001243598A1 true AU2001243598A1 (en) 2001-09-24

Family

ID=26884614

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001243598A Abandoned AU2001243598A1 (en) 2000-03-13 2001-03-13 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade

Country Status (3)

Country Link
US (3) US6852761B2 (en)
AU (1) AU2001243598A1 (en)
WO (1) WO2001068605A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852761B2 (en) * 2000-03-13 2005-02-08 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
JP2003528076A (en) * 2000-03-20 2003-09-24 メルク シャープ エンド ドーム リミテッド Sulfonamide-substituted bridged bicycloalkyl derivatives
DE10037146A1 (en) * 2000-07-29 2002-02-07 Merck Patent Gmbh acetamide derivatives
UA75093C2 (en) 2000-10-06 2006-03-15 Dimensional Pharm Inc Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors
US6610701B2 (en) * 2001-02-09 2003-08-26 Merck & Co., Inc. Thrombin inhibitors
MXPA04003163A (en) * 2001-10-03 2004-07-08 Pharmacia Corp 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade.
TW200410921A (en) * 2002-11-25 2004-07-01 Hoffmann La Roche Mandelic acid derivatives
US7550474B2 (en) 2003-04-10 2009-06-23 Johnson & Johnson Pharmaceuticals Research & Development, L.L.C. Substituted phenyl acetamides and their use as protease inhibitors
US20060227347A1 (en) * 2005-03-30 2006-10-12 Quark, Inc. Systems and methods for importing color environment information
US20060227146A1 (en) * 2005-03-30 2006-10-12 Quark, Inc. Systems and methods for media production color management
US8153590B2 (en) 2007-09-28 2012-04-10 Portola Pharmaceuticals, Inc. Antidotes for factor Xa inhibitors and methods of using the same
MX2011004907A (en) 2008-11-14 2011-07-29 Portola Pharm Inc Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents.
PT2414517T (en) 2009-03-30 2016-12-27 Portola Pharm Inc ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS FOR USE OF THE FACTOR
CN102625712B (en) * 2009-07-15 2017-07-25 博尔托拉制药公司 Unit dose formulations and its application method for the antidote of factor XA inhibitor
TW201444798A (en) 2013-02-28 2014-12-01 必治妥美雅史谷比公司 Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors
US9828345B2 (en) 2013-02-28 2017-11-28 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374849A (en) * 1966-09-28 1968-03-26 Lawrence E. Redman Electric vehicle
US3444946A (en) * 1966-10-03 1969-05-20 Nelson J Waterbury Self-electric-powered vehicle
US3556239A (en) * 1968-09-23 1971-01-19 Joseph W Spahn Electrically driven vehicle
US4314160A (en) * 1980-04-25 1982-02-02 Leon Boodman Wind turbine generator for electrical powered vehicles
JPS5910541A (en) 1982-07-09 1984-01-20 Takeda Chem Ind Ltd Quinone compound
JPS60255749A (en) 1984-05-31 1985-12-17 Univ Nagoya Quinone derivative
US5304658A (en) 1984-08-01 1994-04-19 Takeda Chemical Industries, Ltd. Quinone derivatives, their production and use
IL81264A (en) 1986-01-30 1990-11-05 Takeda Chemical Industries Ltd Quinone derivatives,their production and pharmaceutical compositions containing them
DE3826846A1 (en) 1988-08-06 1990-02-08 Goedecke Ag ALKOXY-4 (1H) -PYRIDONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS DRUGS
US5008267A (en) 1988-10-29 1991-04-16 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same
GB9216272D0 (en) 1991-08-15 1992-09-09 Ici Plc Substituted heterocycles
US5441960A (en) 1992-04-16 1995-08-15 Zeneca Limited 1-pyrimidinylacetamide human leukocyte elastate inhibitors
CA2133657A1 (en) 1992-04-16 1993-10-28 Peter R. Bernstein Substituted derivatives
JPH07233148A (en) * 1993-12-27 1995-09-05 Terumo Corp Piperidine derivative and medicinal preparation containing the same
US5642984A (en) * 1994-01-11 1997-07-01 Northeastern University Helical turbine assembly operable under multidirectional fluid flow for power and propulsion systems
US5618792A (en) 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US6011158A (en) 1994-12-13 2000-01-04 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US5656645A (en) 1994-12-13 1997-08-12 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US5658930A (en) 1994-12-13 1997-08-19 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
HUT77888A (en) 1994-12-13 1998-09-28 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US5948785A (en) 1995-04-27 1999-09-07 The Green Cross Corporation Heterocyclic amide compounds and pharmaceutical use of the same
US5612378A (en) 1995-06-06 1997-03-18 3-Dimensional Pharmaceuticals, Inc. Bis-arylsulfonylaminobenzamide derivatives and the use thereof as factor Xa inhibitors
US5741819A (en) * 1995-06-07 1998-04-21 3-Dimensional Pharmaceuticals, Inc. Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors
AU703744B2 (en) 1995-06-27 1999-04-01 Merck & Co., Inc. Pyridinone-thrombin inhibitors
JP2921606B2 (en) 1995-11-08 1999-07-19 ケーニツヒ ウント バウエル−アルバート アクチエンゲゼルシヤフト Folding device
CA2245811A1 (en) 1996-02-22 1997-08-28 Merck & Co., Inc. Pyridinone thrombin inhibitors
DE69709727T2 (en) 1996-04-23 2002-08-08 MERCK & CO., INC. PARAZINON THROMBIN INHIBITORS
US5668289A (en) 1996-06-24 1997-09-16 Merck & Co., Inc. Pyridinone thrombin inhibitors
AU724191B2 (en) 1996-08-29 2000-09-14 Merck & Co., Inc. Integrin antagonists
AU4172397A (en) 1996-09-06 1998-03-26 Biochem Pharma Inc. Lactam inhibitors of thrombin
US6271238B1 (en) 1996-09-06 2001-08-07 Nippon Kayaku Kabushiki Kaisha Acetamide derivatives and protease inhibitors
WO1998010763A1 (en) 1996-09-13 1998-03-19 Merck & Co., Inc. Thrombin inhibitors
US5872138A (en) 1996-09-13 1999-02-16 Merck & Co., Inc. Thrombin inhibitors
CA2268381A1 (en) 1996-10-11 1998-04-23 Cor Therapeutics, Inc. Selective factor xa inhibitors
WO1998016525A1 (en) 1996-10-11 1998-04-23 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
US5869487A (en) 1996-10-24 1999-02-09 Merck & Co., Inc. Pyrido 3,4-B!pyrazines for use as thrombin inhibitors
DE69719775T2 (en) 1996-10-24 2004-02-05 Merck & Co., Inc. THROMBIN INHIBITORS
CN1088706C (en) 1996-10-25 2002-08-07 卫福有限公司 Novel heterocyclic amide compound and medical use thereof
US5714819A (en) * 1996-10-28 1998-02-03 Ametek, Inc. Motor having universal fan end bracket
JP2001508796A (en) 1997-01-22 2001-07-03 メルク エンド カンパニー インコーポレーテッド Thrombin inhibitors
US5792779A (en) 1997-02-19 1998-08-11 Merck & Co., Inc. Pyridinone thrombin inhibitors
EP0969840A4 (en) 1997-03-24 2001-02-28 Merck & Co Inc Thrombin inhibitors
US5866573A (en) 1997-04-21 1999-02-02 Merck & Co., Inc. Pyrazinone thrombin inhibitors
IL123986A (en) 1997-04-24 2011-10-31 Organon Nv Serine protease inhibiting antithrombotic agents and pharmaceutical compositions comprising them
CN1254345A (en) 1997-05-02 2000-05-24 阿克佐诺贝尔公司 Serine protease inhibitors
ATE306261T1 (en) 1997-06-26 2005-10-15 Lilly Co Eli ANTITHROMBOTIC AGENTS
JP2002512633A (en) 1997-06-26 2002-04-23 イーライ・リリー・アンド・カンパニー Antithrombotic agent
EP1019045B1 (en) 1997-06-26 2005-06-08 Eli Lilly And Company Antithrombotic agents
JP2001514227A (en) 1997-09-05 2001-09-11 メルク エンド カムパニー インコーポレーテッド Pyrazinone thrombin inhibitors
ATE344246T1 (en) 1997-11-26 2006-11-15 Ortho Mcneil Pharm Inc HETEROARYL AMINOGUANIDINE AND ALKOXYGUANIDINE DERIVATIVES AND THEIR USE AS PROTEASE INHIBITORS
AU1605699A (en) 1997-11-26 1999-06-15 Corvas International, Inc. Substituted 3-amino-2-hydroxyphenylacetamide derivatives as enzyme inhibitors (ii)
PT1049703E (en) 1998-01-20 2003-06-30 Warner Lambert Co N-2- (5-BENZYLOXYCARBONYLAMINO-6-OXO-2- (4-FLUOROPHENYL) -1,6-DIHYDRO-1-PYRIMIDINYL) ACETOXYL-ASPARTIC ACID AS INHIBITOR OF THE INVENTION INTERLEUCINA-1BETA IN VIVO
WO1999043660A1 (en) 1998-02-26 1999-09-02 Neurogen Corporation Substituted 1,4-dihydro-4-oxonicotinic carboxamides: gaba brain receptor ligands
GB9806102D0 (en) 1998-03-20 1998-05-20 Merck Sharp & Dohme Therapeutic agents
DE69918824T2 (en) 1998-05-06 2004-11-25 Hill-Rom Services, Inc., Batesville MATTRESS / CUSHION CONSTRUCTION
CA2329914A1 (en) 1998-05-19 1999-11-25 Merck & Co., Inc. Pyrazinone thrombin inhibitors
JP2002516326A (en) 1998-05-26 2002-06-04 メルク エンド カムパニー インコーポレーテッド Imidazopyridine thrombin inhibitors
JP2003520185A (en) 1998-06-03 2003-07-02 コーテック インコーポレーテッド Α-Ketooxadiazoles as serine protease inhibitors
CN1224629C (en) 1998-06-11 2005-10-26 三维药物公司 Phrazinone protease inhibitors
DE69912379T2 (en) 1998-08-14 2004-05-06 Pfizer Inc. Antithrombotic agents
AU758237B2 (en) 1998-09-28 2003-03-20 Merck & Co., Inc. Thrombin inhibitors
US6610692B1 (en) 1998-10-30 2003-08-26 Merck & Co., Inc. Thrombin inhibitors
AU752186B2 (en) 1998-10-30 2002-09-12 Merck & Co., Inc. Thrombin inhibitors
DE19851421A1 (en) 1998-11-07 2000-05-11 Boehringer Ingelheim Pharma New pyrimidines, their production and use
FR2786482B1 (en) 1998-11-27 2002-08-09 Synthelabo NOVEL 2-PYRIDONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
AU3127900A (en) 1998-12-23 2000-07-31 Du Pont Pharmaceuticals Company Thrombin or factor xa inhibitors
HUP0201242A3 (en) 1999-05-19 2003-02-28 Pharmacia Corp St Louis Substituted polycyclic aryl and heteroaryl pyrimidinone and triazinone derivatives useful as anticoagulants and pharmaceutical compositions containing them
MXPA01011806A (en) 1999-05-19 2003-09-04 Pharmacia Corp Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents.
KR20010113970A (en) 1999-05-19 2001-12-28 추후보정 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
US6852761B2 (en) * 2000-03-13 2005-02-08 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
AU2001249870A1 (en) 2000-04-05 2001-10-23 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade

Also Published As

Publication number Publication date
US20030236231A1 (en) 2003-12-25
US20040138275A1 (en) 2004-07-15
US20020025947A1 (en) 2002-02-28
US6660885B2 (en) 2003-12-09
WO2001068605A1 (en) 2001-09-20
US6852761B2 (en) 2005-02-08

Similar Documents

Publication Publication Date Title
IL146244A0 (en) Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
AU2001243598A1 (en) Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
AU2002237676A1 (en) Methods and materials for the synthesis of organic products
IL146245A0 (en) Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
AU2001238108A1 (en) Single phase gels for the prevention of adhesions
AU2002224927A1 (en) Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
AU2001238426A1 (en) Prepaints and methods of preparing paints from the prepaints
AU2001292582A1 (en) C-nitroso compounds and use thereof
AU4677399A (en) Inhibitors of H+K+-ATPase
AU2001259817A1 (en) Methods of and compounds for inhibiting calpains
AU2001275352A1 (en) Anti-pilferage system
AU2002367752A1 (en) Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
AU2001219236A1 (en) Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
AU2001259448A1 (en) Fluorous tagging compounds and methods of increasing the fluorous nature of compounds
AU2002335658A1 (en) Treatment of neurologic hemorrhage
AU2001222501A1 (en) Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
AU2001262111A1 (en) Aryl and heteroaryl sulfonates
AU2001217827A1 (en) Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
AU2000267048A1 (en) Bases for cutout circuits and method for the production thereof
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
AU2002325608A1 (en) Device for locking the final positions of moving switch points
AU2002361074A1 (en) Solvent for treating polystyrene resin and method of treating polystyrene resin with the same
AU2001286584A1 (en) Inhibition of protein-protein interaction
AU2001244271A1 (en) Compounds capable of binding with the cytoskeleton
AU2002337805A1 (en) Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade